GlassScriptPhysician profile
Scott P Tannehill
NPI 1902897440
$7,613.09
in general payments reported to CMS, 2019-2025
62 companies · $2,028 in 2025
The $2,028 reported for 2025 was more than what 90% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $346 · 2021: $249 · 2022: $596 · 2023: $2,151 · 2024: $1,862 · 2025: $2,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,703 · Travel and Lodging: $266 · Education: $72.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,702.61 |
| Travel and Lodging | $265.75 |
| Education | $72.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionrt, INC. | $811.41 | 2023-2025 | |
| Pfizer INC. | $440.39 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $359.39 | 2019-2025 | Lynparza, Enhertu, Imfinzi |
| Janssen Biotech, INC. | $356.90 | 2019-2025 | Darzalex, Carvykti, Rybrevant |
| Merck Sharp & Dohme LLC | $325.71 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Bayer Healthcare Pharmaceuticals INC. | $311.48 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $284.28 | 2019-2025 | Libtayo |
| Novartis Pharmaceuticals Corporation | $273.81 | 2021-2025 | |
| Novocure INC. | $253.48 | 2020-2025 | Optune, Optune Lua (Novottf-200t) |
| Elekta, INC. | $244.97 | 2020 | |
| Daiichi Sankyo INC. | $238.31 | 2023-2025 | Enhertu, Injectafer |
| Abbvie INC. | $229.54 | 2023-2025 | Venclexta |
| Seagen INC. | $208.05 | 2022-2025 | Tukysa, Padcev |
| Myriad Genetic Laboratories, INC. | $197.10 | 2021-2024 | Prolaris |
| Takeda Pharmaceuticals U.S.A., INC. | $182.75 | 2022-2025 | Fruzaqla, Alunbrig, Ninlaro |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $178.98 | 2024-2025 | Illuccix |
| Tactile Systems Technology INC | $155.78 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Springworks Therapeutics, INC. | $141.39 | 2024-2025 | Ogsiveo |
| Progenics Pharmaceuticals, INC. | $137.96 | 2022-2025 | Pylarify |
| Advanced Accelerator Applications | $137.29 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $128.28 | 2022-2025 | Opdivo |
| Eisai INC. | $113.27 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $112.61 | 2023-2025 | Orgovyx |
| Astellas Pharma US INC | $105.40 | 2023-2024 | Padcev, Xtandi |
| Tersera Therapeutics LLC | $100.69 | 2022-2025 | Zoladex |
| Boston Scientific Corporation | $96.75 | 2019-2025 | Spaceoar Vue System - 10ml |
| Medtronic, INC. | $93.95 | 2022 | |
| Ge Healthcare | $92.90 | 2022-2025 | |
| Incyte Corporation | $92.05 | 2023-2025 | Monjuvi, Jakafi, Pemazyre |
| Gilead Sciences, INC. | $81.45 | 2022-2024 | Trodelvy |
| Blue Earth Diagnostics | $67.23 | 2021-2023 | |
| Aveo Pharmaceuticals, INC. | $62.82 | 2022-2023 | Fotivda |
| Sun Pharmaceutical Industries INC. | $62.41 | 2023 | Yonsa, Odomzo |
| Ipsen Biopharmaceuticals, INC | $60.94 | 2023-2024 | Onivyde, Tazverik |
| Puma Biotechnology, INC. | $60.93 | 2022-2023 | |
| Sobi, INC | $58.74 | 2024-2025 | |
| Lilly USA, LLC | $57.38 | 2019-2021 | |
| Genmab U.S., INC. | $53.81 | 2024-2025 | Epkinly |
| Emd Serono, INC. | $53.48 | 2023-2025 | Tepmetko |
| Iovance Biotherapeutics, INC. | $46.42 | 2025 | Amtagvi |
| Siemens Medical Solutions USA, INC. | $41.30 | 2023 | Aria Radiation Therapy Management Software |
| Adaptive Biotechnologies Corporation | $37.19 | 2024-2025 | Clonoseq |
| Intuitive Surgical, INC. | $34.82 | 2024 | |
| Tempus Ai, INC | $34.40 | 2024-2025 | Xt Cdx |
| Dendreon Pharmaceuticals LLC | $33.21 | 2025 | Provenge |
| Aurobindo Pharma USA, INC. | $32.79 | 2020 | |
| Mylan Institutional INC. | $29.80 | 2023 | Ogivri, Fulphila |
| Janssen Pharmaceuticals, INC | $27.85 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $26.16 | 2023 | Imbruvica |
| Glaxosmithkline, LLC. | $24.92 | 2025 | Ojjaara |
| Adc Therapeutics America, INC. | $24.83 | 2024 | |
| Teleflex LLC | $23.47 | 2025 | Barrigel |
| Kite Pharma, INC. | $21.52 | 2025 | Yescarta |
| Genzyme Corporation | $21.20 | 2023 | |
| Acrotech Biopharma INC. | $19.10 | 2021 | |
| Bioprotect Medical, INC. | $18.94 | 2025 | Bioprotect Balloon Implant System |
| Celgene Corporation | $18.20 | 2025 | Opdivo |
| Mirati Therapeutics, INC. | $17.45 | 2024 | Krazati |
| Verity Pharmaceuticals INC. | $15.35 | 2022 | |
| Isoray, INC | $13.45 | 2020 | |
| Karyopharm Therapeutics INC. | $13.37 | 2024 | Xpovio |
| Cardinal Health 414 LLC | $13.29 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Tannehill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.